Significant association between DRD3 gene body methylation and schizophrenia
Significant association between DRD3 gene body methylation and schizophrenia
复制标题
DRD3基因体甲基化与精神分裂症之间的显着相关性
DOI:
10.1016/j.psychres.2014.08.032
复制
发表时间:
2014-12-30
影响因子:
11.3
通讯作者:
Duan, Shiwei
中科院分区:
文献类型:
--
作者:
Dai, Dongjun;Cheng, Jia;Duan, Shiwei
The current study was the first one to reveal the contribution of DRD3 methylation to the risk of different (SCZ) subtypes. This study comprised a total of 30 paranoid (15 males and 15 females) and 29 undifferentiated (15 males and 14 females) SCZ patients and 26 age- and gender-matched controls. Our results showed a significant association of CpG2 with SCZ. A breakdown analysis by gender showed that CpG2 and CpG3 methylation were significantly higher in male patients than male controls, and that CpG5 methylation was significantly higher in female patients than female controls. A further breakdown analysis by both gender and SCZ subtype showed that CpG2 and CpG3 methylation were significantly higher in male paranoid SCZ and male undifferentiated SCZ than male controls. In contrast, CpG2 and CpG3 methylation were significantly lower in female undifferentiated SCZ than female controls. Additionally, CpG5 methylation was significantly higher in female paranoid SCZ than female controls. In conclusion, our findings supported that DRD3 gene body hypermethylation was significantly associated with the risk of SCZ. Future study is needed to clarify the mechanisms by which DRD3 gene body hypermethylation contributes to the risk of SCZ. (C) 2014 Elsevier Ireland Ltd. All rights reserved.